NEW YORK (GenomeWeb News) – Roche said this morning that it will dissolve its Applied Science Business Area by the end of this year and integrate products from that business with other parts of its Diagnostics Business Area.

As part of the reorganization, Roche said that it will cut around 110 positions in Penzberg, Germany and 60 positions in Branford, Conn., which is the home of its 454 Life Sciences business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.